Describing the Prevalence of Neural Tube Defects Worldwide: A Systematic Literature Review.
Zaganjor I, Sekkarie A, Tsang BL, Williams J, Razzaghi H, Mulinare J, Sniezek JE, Cannon MJ, Rosenthal J. · 2016
Read Describing the Prevalence of Neural Tube Defects Worldwide: A Systematic Literature Review. by Zaganjor I, Sekkarie A, Tsang BL, Williams J, Razzaghi H, Mulinare J, Sniezek JE, Cannon MJ, Rosenthal J. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4827875.txt.
Introduction
Ibrahim Zaganjor leads ten authors in PLoS ONE in 2016 mapping neural tube defects worldwide. These birth defects of brain and spine can often be prevented with folic acid, yet no full count of their global burden existed. The team searched literature, registries, and reports from 1990 to 2014, keeping sources covering over five thousand births.
Data came from just 75 of the world's countries, and 120 of 194 member states had none at all. Rates swung widely within every region, from under one to nearly two hundred per ten thousand births in the widest range. Registry coverage rose steeply with national income, reaching nine in ten rich countries and none of the poorest. The authors call for stronger counting where the need is greatest.
Catalog record
| CREATOR | Zaganjor I, Sekkarie A, Tsang BL, Williams J, Razzaghi H, Mulinare J, Sniezek JE, Cannon MJ, Rosenthal J. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| LICENSE | CC0 1.0 Universal |
| RIGHTS | CC0 |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Describing the Prevalence of Neural Tube Defects Worldwide: A Systematic Literature Review By Ibrahim Zaganjor, Ahlia Sekkarie, Becky L Tsang, Jennifer Williams, Hilda Razzaghi, Joseph Mulinare, Joseph E Sniezek, Michael J Cannon, Jorge Rosenthal, Rogelio Cruz-Martinez Published in: PLoS ONE DOI: 10.1371/journal.pone.0151586 ABSTRACT Abstract Background Folate-sensitive neural tube defects (NTDs) are an important, preventable cause of morbidity and mortality worldwide. There is a need to describe the current global burden of NTDs and identify gaps in available NTD data. Methods and Findings We conducted a systematic review and searched multiple databases for NTD prevalence estimates and abstracted data from peer-reviewed literature, birth defects surveillance registries, and reports published between January 1990 and July 2014 that had greater than 5,000 births and were not solely based on mortality data. We classified countries according to World Health Organization (WHO) regions and World Bank income classifications. The initial search yielded 11,614 results; after systematic review we identified 160 full text manuscripts and reports that met the inclusion criteria. Data came from 75 countries. Coverage by WHO region varied in completeness (i.e., % of countries reporting) as follows: African (17%), Eastern Mediterranean (57%), European (49%), Americas (43%), South-East Asian (36%), and Western Pacific (33%). The reported NTD prevalence ranges and medians for each region were: African (5.2–75.4; 11.7 per 10,000 births), Eastern Mediterranean (2.1–124.1; 21.9 per 10,000 births), European (1.3–35.9; 9.0 per 10,000 births), Americas (3.3–27.9; 11.5 per 10,000 births), South-East Asian (1.9–66.2; 15.8 per 10,000 births), and Western Pacific (0.3–199.4; 6.9 per 10,000 births). The presence of a registry or surveillance system for NTDs increased with country income level: low income (0%), lower-middle income (25%), upper-middle income (70%), and high income (91%). Conclusions Many WHO member states (120/194) did not have any data on NTD prevalence. Where data are collected, prevalence estimates vary widely. These findings highlight the need for greater NTD surveillance efforts, especially in lower-income countries. NTDs are an important public health problem that can be prevented with folic acid supplementation and fortification of staple foods. INTRODUCTION Neural tube defects (NTDs), serious birth defects of the brain and spine, are a major, preventable public health burden. Globally, it is estimated that approximately 300,000 babies are born each year with NTDs [1], resulting in approximately 88,000 deaths and 8.6 million disability-adjusted life years (DALYs) [2, 3]. In low income countries, NTDs may account for 29% of neonatal deaths due to observable birth defects [4]. As morbidity and mortality from infectious diseases are decreasing worldwide, the contribution of birth defects to under-5 morbidity and mortality will continue to increase proportionally [5]. Conclusive evidence from clinical trials has led to recommendations for adequate periconceptional folic acid intake to reduce the occurrence of a NTD-affected pregnancy [6]; as a result, mandatory folic acid fortification (FAF) of staple cereal grains has been legislated in many countries as recently reviewed [7, 8]. Long-term surveillance of NTDs in countries that have successfully implemented fortification, such as the United States, Canada, Costa Rica, South Africa, and Chile, and data from a supplementation program in China suggest that folic acid interventions can reduce NTD prevalence to as low as 5–6 per 10,000 pregnancies [8, 9]. Because birth defects are a major cause of under-5 mortality, adequate surveillance data are needed for prevention and evaluation purposes. This is particularly important for birth defects that have well-established interventions. For example, depending on the baseline prevalence, it is estimated that the majority of NTDs can be prevented with folic acid [4, 10]. However, national surveillance of NTDs and other birth defects remains limited worldwide. To promote global birth defects surveillance efforts, in 2010 the World Health Assembly issued a resolution urging member states “to develop and strengthen registration and surveillance systems for birth defects” [11]. There have been recent efforts to model and estimate the worldwide burden of NTDs and other major birth defects [1, 12]. Some data are also available from systematic reviews, but most of the reviews are specific to certain regions or income levels [13–15]. However, an accurate estimate of the prevalence of NTDs in most countries is still unknown primarily due to insufficient and fragmented data collection. To complement previous efforts, the goal of our review is to describe the most current prevalence estimates of NTDs worldwide, while highlighting key methodological differences and gaps in available data. METHODS Search Strategy We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (S1 Document) [16]. We searched the following bibliographic databases for English and Spanish language literature published between January 1990 and July 2014: the Cochrane Collaboration, CINAHL, Embase, POPLINE, PubMed, Global Health (CDC resource), Web of Science, and several World Health Organization (WHO) library resources (African Index Medicus, Index Medicus for the Eastern Mediterranean Region, Spanish Health Sciences Bibliographic Index, Index Medicus for the South-East Asian Region, Latin American and Caribbean Health Sciences Literature, and the World Health Organization Library Information System). We adapted the search terms to each database and included keywords for neural tube defects, congenital anomalies, epidemiology, registries, and hospitals. We also identified international birth defect registries and searched the databases/reports of the European Surveillance of Congenital Anomalies (EUROCAT), the International Clearinghouse for Birth Defects Surveillance and Research (ICBDSR), and other reports. Finally, we included additional studies and reports from hand searching reference lists of systematic reviews. Inclusion/Exclusion Criteria and Algorithm Review We included case-control and cross-sectional studies and reports with either a reported prevalence of NTDs (defined as anencephaly/spina bifida/encephalocele), or numerator (number of reported NTD cases) and denominator data (number of births in the study population). Many studies reported on NTDs without explaining how they defined them; we included these studies in order to increase coverage. We excluded the following: 1) case reports and supplementation trials; 2) studies that only included anencephaly and/or encephalocele; 3) studies that only counted non-NTDs per our definition, such as amniotic band sequence, chromosomal abnormalities, or spina bifida occulta; 4) studies with a denominator of fewer than 5,000 total births given the high degree of uncertainty of NTD prevalence in such a small sample size; 5) studies that reported prevalence in graphs without point estimates; 6) studies that only used mortality data; 7) studies with data based only on prenatal diagnosis; 8) and studies whose data were collected prior to 1990. We also excluded studies that reported data after a contamination event that may have caused an increase in NTD prevalence estimates. We developed an algorithm to ensure that the most current and relevant data for each country were included in our review. If multiple studies were available for the same region or country but at different time periods, we included the study with the most recent data. In instances where multiple studies existed for one country from different geographic locations, all studies from that country were included, except if nationally representative data were available. In these cases, only the nationally representative study was used. However, if one study reported nationwide data that were not nationally representative, we still included studies from individual regions. Data Abstraction and Risk-of-Bias (RoB) Assessment We abstracted data on the number of cases (numerator), the birth cohort (denominator), and calculated prevalence into a standard table. Three authors reviewed the abstracted data from